
GC62427
Cdc7-IN-5
Also known as ethyl 4-hydroxy-2-(7-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)-5-(pyrrolo[2,3-b]pyridin-3-ylidenemethyl)furan-3-carboxylate
Cdc7-IN-5 (compound I-B) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-B· Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle
ChemicalCAS1402057-86-6MW445.47FormulaC25H23N3O5
- CAS number
- 1402057-86-6
- Molecular weight
- 445.47
- Formula
- C25H23N3O5
- Solubility
- DMSO : 12·5 mg/mL (28·06 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- JSRLUFXDTSIAKH-UHFFFAOYSA-N
- Catalogue number
- GC62427
- Brand
- GLPBIO
Computed properties PubChem CID 136338209 · XLogP 3.9 · TPSA 97.4 Ų · H-bond donors 1
- XLogP
- 3.9
- TPSA
- 97.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES CCOC(=O)C1=C(OC(=C1O)C=C2C=NC3=C2C=CC=N3)N4CCC5=C(C4)C=C(C=C5)OC
Computed descriptors from PubChem (CID 136338209), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il